Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phase I study]

T Taguchi1

  • 1Osaka University, Japan Society for Cancer Chemotherapy.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

This study critiques the initial phase of clinical trial guidelines for cancer drugs, focusing on implementation details. It advocates for public education on the necessity of scientifically rigorous, cost-effective trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effect of CPT-11 in combination with interferon-alpha against human colon carcinoma heterotransplanted in nude mice: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

[Correlation of DBA lectin binding and malignancy in breast cancers: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

Pokeweed mitogen induces p55 interleukin-2 receptor expression on human monocytes and its effect on interleukin-2 activated monocyte cytotoxicity.

Immunological investigations·1992
Same author

[Athyreotic congenital hypothyroidism in two sisters].

Nihon Naibunpi Gakkai zasshi·1992
Same author

Immunological identification of a Cl- channel protein in electric organs of Narke japonica.

Biochemical and biophysical research communications·1992
Same author

DNA synthesis and related enzymes altered in compensatory lung growth in rats.

Scandinavian journal of clinical and laboratory investigation·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Biostatistics

Context:

  • Critique of "Guidelines For Methods To Evaluate Drugs for Malignant Tumors at the Clinical Level."
  • Focus on the first phase of clinical trial implementation.
  • Addresses objectives, personnel, facilities, patient selection, and trial design.

Purpose:

  • To present criticisms and proposals for improving the implementation of early-phase cancer drug evaluations.
  • To highlight areas needing refinement in current clinical trial methodologies.
  • To emphasize the need for public awareness regarding scientific trial requirements.

Summary:

  • The study evaluates the practical aspects of early-phase cancer drug trials based on existing guidelines.
  • Identifies specific shortcomings in objectives, management, resources, patient criteria, and study design.

Related Experiment Videos

  • Proposes enhancements for more effective and efficient trial execution.

    • Impact:

    • Aims to improve the rigor and efficiency of clinical trials for malignant tumors.
    • Contributes to the scientific discourse on optimizing drug evaluation processes.
    • Stresses the importance of informed public engagement in scientific research and development.